Chromoendoscopy should be the standard method and more widely used for cancer surveillance colonoscopy in ulcerative colitis - Con

Inflammatory Bowel Diseases

Volumn 13, Issue 10, 2007, Pages 1273-1274

  Ullman, Thomas A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDIGO CARMINE; METHYLENE BLUE;

BIOPSY; CANCER RISK; CHROMOENDOSCOPY; COLON RESECTION; COLONOSCOPY; COLORECTAL CANCER; CROHN DISEASE; DIAGNOSTIC ACCURACY; DYSPLASIA; ENDOSCOPIC MUCOSAL RESECTION; HUMAN; MORBIDITY; MORTALITY; POLYPECTOMY; PRIORITY JOURNAL; SHORT SURVEY; ULCERATIVE COLITIS;

BIOPSY; COLITIS, ULCERATIVE; COLONIC NEOPLASMS; COLONOSCOPY; COLORING AGENTS; DIAGNOSIS, DIFFERENTIAL; HUMANS; MASS SCREENING; PRECANCEROUS CONDITIONS; REPRODUCIBILITY OF RESULTS; RISK FACTORS;

EID: 35349027901     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20194     Document Type: Short Survey

References (12)

1. Ullman TA. Preventing neoplastic progression in ulcerative colitis. J Clin Gastroenterol. 2005;39:S66-S69.
2. Rubin CE, Haggitt RC, Burmer GC, et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology. 1992;103:1611-1620.
3. Eaden JA, Ward BA, Mayberry JF. How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance. Gastrointest Endosc. 2000;51:123-128.
4. Ullman T, Croog V, Harpaz N, Sachar D, Itzkowitz S. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology. 2003;125:1311-1319.
5. Kiesslich R, Fritsch J, Holtmann M, et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology. 2003;124:880-888.
6. Hurlstone DP, McAlindon ME, Sanders DS, Koegh R, Lobo AJ, Cross SS. Further validation of high-magnification chromoscopic-colonoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology. 2004;126:376-378.
7. Hurlstone DP, Sanders DS, Lobo AJ, McAlindon ME, Cross SS. Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation. Endoscopy. 2005;37:1186-1192.
8. Rutter MD, Saunders BP, Schofield G, Forbes A, Price AB, Talbot IC. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut. 2004;53:256-260.
9. Kiesslich R, Neurath MF. Surveillance colonoscopy in ulcerative colitis: magnifying chromoendoscopy in the spotlight. Gut. 2004;53:165-167.
10. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985;312:1604-1608.
11. Rutter MD, Saunders BP, Wilkinson KH, et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology. 2006;130:1030-1038.
12. Hurlstone DP, Sanders DS, Hunter MD, et al. Endoscopic mucosal resection for flat neoplasia in chronic ulcerative colitis: can we change the endoscopic management paradigm? Gut. 2006.